It may take a few months to over a year to show significant improvements in body weight and blood sugar control
Retatrutide is an unlicensed investigational triple incretin receptor agonist by Eli Lilly
doi: 10.3389/fcdhc.2025.1590530 Received 09 March 2025 Accepted 18 June 2025 Published 10 July 2025 Volume 6 - 2025 Edited by Angelo Maria Patti, University of Palermo, Italy Reviewed by Anapaula Sommer Vinagre, Federal University of Rio Grande do Sul, Brazil Jun Eguchi, Okayama University, Japan Updates Copyright 2025 Hammad, Zafar, Ullah, Faisal, Iftikhar, Waheed, Muzaffar, Ahmed, Ashraf, Zahid, Akhtar and Mahmmoud Fadelallah Eljack
Furthermore, certain foods and high stress levels are two large factors that can worsen IBS, as discomfort often arises after eating or during periods of increased stress
Exenatide: Also used in 2 studies, reflecting ongoing exploration of various GLP-1 options